Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy

Early response could be obtained in most patients with relapsed or refractory B cell lymphoblastic leukemia (R/R B-ALL) treated with chimeric antigen receptor T-cell (CAR-T) therapy, but relapse occurs in some patients. There is no consensus on treatment strategy post CAR-T cell therapy. In this ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Ma, Yuhan, Shen, Ziyuan, Chen, Huimin, Ma, Ruixue, Yan, Dongmei, Shi, Ming, Wang, Xiangmin, Song, Xuguang, Sun, Cai, Cao, Jiang, Cheng, Hai, Zhu, Feng, Sun, Haiying, Li, Depeng, Li, Zhenyu, Zheng, Junnian, Xu, Kailin, Sang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586453/
https://www.ncbi.nlm.nih.gov/pubmed/34777367
http://dx.doi.org/10.3389/fimmu.2021.755549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586453/
https://www.ncbi.nlm.nih.gov/pubmed/34777367
http://dx.doi.org/10.3389/fimmu.2021.755549

Ejemplares similares